Cited by 8Glioma Diagnosis and TreatmentCancer Cells and Metastasis3D Printing in Biomedical Research

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Time series assessment of the effects of hypoxic stress on glioma tumorsphere development within engineered microscale niches

Cha, Junghwa, Kim, Pilnam·2019·Biomaterials

Abstract

A rapidly outgrowing tumor mass is liable to suffer from a shortage of oxygen and nutrients due to the diffusion limit. These features evidently prevail in glioblastoma, resulting in extensive hypoxic regions throughout the tumor mass. While there may be a strong link between hypoxic regions and glioblastoma malignancy, the effects of hypoxia stress on each tumorigenic step and their interrelation during the progression remain unexplored due to the limited information from current assay platforms. Here, we suggest a tumor microenvironment array platform (TMAP) to describe a time series assessment of glioblastoma tumorsphere (TS) within a microscale niche. TMAP enables to observe the overall tumorigenic process of glioblastoma TSs over the cultivation time, simultaneously quantifying the features with the biophysical parameters. Through the time series assessment, we observed the induction of hypoxic stress within the mature TSs, which rendered intratumoral phenotypic changes to become more malignant and modulated their microenvironmental niches to enhance angiogenic proliferation, immune recruitment, and even drug response. Based on the finding that the tumorigenic parameters were highly correlated only in mature TSs, we conclude that the effects of hypoxic stress systematically affect the process that drives a glioblastoma to higher malignancy.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2018.12.018

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 28

  1. Joyce, 2009, Microenvironmental regulation of metastasis, Nat. Rev. Canc., 9, 239, 10.1038/nrc2618 · DOI · Paper page
  2. Egeblad, 2010, Tumors as organs: complex tissues that interface with the entire organism, Dev. Cell, 18, 884, 10.1016/j.devcel.2010.05.012 · DOI
  3. Gilbertson, 2007, Making a tumour's bed: glioblastoma stem cells and the vascular niche, Nat. Rev. Canc., 7, 733, 10.1038/nrc2246 · DOI
  4. Tafani, 2011, Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma, J. Neuroinflammation, 8, 32, 10.1186/1742-2094-8-32 · DOI
  5. Cheng, 2013, Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth, Cell, 153, 139, 10.1016/j.cell.2013.02.021 · DOI · Paper page
  6. da Fonseca, 2013, Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies, Clin. Dev. Immunol., 2013
  7. Marusyk, 2012, Intra-tumour heterogeneity: a looking glass for cancer?, Nat. Rev. Canc., 12, 323, 10.1038/nrc3261 · DOI
  8. Yin, 2016, Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis, Nat. Commun., 7, 11311, 10.1038/ncomms11311 · DOI
  9. Gilkes, 2014, Hypoxia and the extracellular matrix: drivers of tumour metastasis, Nat. Rev. Canc., 14, 430, 10.1038/nrc3726 · DOI · Paper page
  10. Weiswald, 2015, Spherical cancer models in tumor biology, Neoplasia, 17, 1, 10.1016/j.neo.2014.12.004 · DOI
  11. Pistollato, 2010, Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma, Stem Cell., 28, 851, 10.1002/stem.415 · DOI
  12. Li, 2009, Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells, Cancer Cell, 15, 501, 10.1016/j.ccr.2009.03.018 · DOI · Paper page
  13. Joseph, 2015, Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis, Cancer Lett., 359, 107, 10.1016/j.canlet.2015.01.010 · DOI
  14. Kitange, 2009, Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts, Neuro Oncol., 11, 281, 10.1215/15228517-2008-090 · DOI
  15. Jain, 2006, Lessons from phase III clinical trials on anti-VEGF therapy for cancer, Nat. Clin. Pract. Oncol., 3, 24, 10.1038/ncponc0403 · DOI
  16. Omuro, 2007, Lessons learned in the development of targeted therapy for malignant gliomas, Mol. Canc. Therapeut., 6, 1909, 10.1158/1535-7163.MCT-07-0047 · DOI
  17. Cha, 2016, Strategies of mesenchymal invasion of patient-derived brain tumors: microenvironmental adaptation, Sci. Rep., 6, 24912, 10.1038/srep24912 · DOI
  18. Cuddapah, 2014, A neurocentric perspective on glioma invasion, Nat. Rev. Neurosci., 15, 455, 10.1038/nrn3765 · DOI
  19. Zanoni, 2016, 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained, Sci. Rep., 6, 19103, 10.1038/srep19103 · DOI · Paper page
  20. Desoize, 1998, Cell culture as spheroids: an approach to multicellular resistance, Anticancer Res., 18, 4147
  21. Desoize, 2000, Multicellular resistance: a paradigm for clinical resistance?, Crit. Rev. Oncol. Hematol., 36, 193, 10.1016/S1040-8428(00)00086-X · DOI
  22. Quail, 2013, Microenvironmental regulation of tumor progression and metastasis, Nat. Med., 19, 1423, 10.1038/nm.3394 · DOI · Paper page
  23. Zujur, 2017, Three-dimensional system enabling the maintenance and directed differentiation of pluripotent stem cells under defined conditions, Sci. Adv., 3, 10.1126/sciadv.1602875 · DOI
  24. Hood, 2002, Role of integrins in cell invasion and migration, Nat. Rev. Canc., 2, 91, 10.1038/nrc727 · DOI
  25. Facciabene, 2011, Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells, Nature, 475, 226, 10.1038/nature10169 · DOI · Paper page
  26. Li, 2013, Hypoxia enhances stemness of cancer stem cells in glioblastoma: an in vitro study, Int. J. Med. Sci., 10, 399, 10.7150/ijms.5407 · DOI
  27. Patel, 2014, Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma, Science, 344, 1396, 10.1126/science.1254257 · DOI · Paper page
  28. Friedrich, 2009, Spheroid-based drug screen: considerations and practical approach, Nat. Protoc., 4, 309, 10.1038/nprot.2008.226 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Cha, J., & Kim, P.
Affiliations
Korea Advanced Institute of Science and Technology (KR)
Corresponding author
Kim, Pilnam
Venue
Biomaterials
Publisher
Elsevier BV
Published
2019-02
Volume
194
Pages
171-182
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2904133339
Cited by
8
References
3
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1
FWCI
0.57
Type
journal article
Language
en
Open access
closed
Locations
  • Biomaterials (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Health and Welfare (HI14C1324)
  • Korea Health Industry Development Institute
  • Ministry of Education (NRF-2018R1A6A3A01012494)
  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning (KAISTHEALTHCARE42)
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
glioblastoma, hypoxia, tumor spheres, tumor microenvironment, tumor malignancy, angiogenesis, drug response, biophysical parameters
MeSH terms
Tumor Hypoxia, Brain Neoplasms, Glioblastoma, Humans, Time Factors, Oxidative Stress, Cell Culture Techniques, Cell Line, Tumor, Tumor Microenvironment, Human Umbilical Vein Endothelial Cells, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review